EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Understanding the Involvement of microRNAs in Mitochondrial Dysfunction and Their Role as Potential Biomarkers and Therapeutic Targets in Parkinson’s Disease

Kamatham Pushpa Tryphena, Urati Anuradha, Rohith Kumar, Shruti Rajan, Saurabh Srivastava, Shashi Bala Singh, Dharmendra Kumar Khatri

Journal of Alzheimer’s Disease · 2023

DOI: 10.3233/jad-220449 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Alzheimer’s Disease, 2023. Verfasst von Kamatham Pushpa Tryphena und 6 weiteren Autor:innen. Beteiligte Einrichtung: Molecular and Cellular Neuroscience Lab, Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPE…. Hauptthemen laut MEDLINE: MicroRNAs, Parkinson Disease, Neurodegenerative Diseases. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson’s disease (PD) is the second most common neurodegenerative disease, affecting the elderly worldwide and causing significant movement impairments. The goal of PD treatment is to restore dopamine levels in the striatum and regulate movement symptoms. The lack of specific biomarkers for early diagnosis, as well as medication aimed at addressing the pathogenic mechanisms to decelerate the progression of dopaminergic neurodegeneration, are key roadblocks in the management of PD. Various pathogenic processes have been identified to be involved in the progression of PD, with mitochondrial dysfunction being a major contributor to the disease’s pathogenesis. The regulation of mitochondrial functions is influenced by a variety of factors, including epigenetics. microRNAs (miRNAs) are epigenetic modulators involved in the regulation of gene expression and regulate a variety of proteins that essential for proper mitochondrial functioning. They are found to be dysregulated in PD, as evidenced by biological samples from PD patients and in vitro and in vivo research. In this article, we attempt to provide an overview of several miRNAs linked to mitochondrial dysfunction and their potential as diagnostic biomarkers and therapeutic targets in PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsParkinson DiseaseNeurodegenerative DiseasesHumansAgedBiomarkersMitochondria

Stichwörter der Autor:innen

BiomarkersParkinson’s diseasemicroRNAmitochondrial dysfunction

Substanzen

MicroRNAsBiomarkers

Autor:innen und Institutionen

  • Molecular and Cellular Neuroscience Lab, Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, Telangana, India.
  • Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, Telangana, India.

Zitieren

APA

Tryphena, K. P., Anuradha, U., Kumar, R., Rajan, S., Srivastava, S., Singh, S. B., & Khatri, D. K. (2023). Understanding the Involvement of microRNAs in Mitochondrial Dysfunction and Their Role as Potential Biomarkers and Therapeutic Targets in Parkinson’s Disease. Journal of Alzheimer’s Disease. https://doi.org/10.3233/jad-220449

Vancouver

Tryphena KP, Anuradha U, Kumar R, Rajan S, Srivastava S, Singh SB, et al. Understanding the Involvement of microRNAs in Mitochondrial Dysfunction and Their Role as Potential Biomarkers and Therapeutic Targets in Parkinson’s Disease. Journal of Alzheimer’s Disease. 2023. doi:10.3233/jad-220449

BibTeX
@article{Tryphena2023,
  author = {Tryphena, Kamatham Pushpa and Anuradha, Urati and Kumar, Rohith and Rajan, Shruti and Srivastava, Saurabh and Singh, Shashi Bala and Khatri, Dharmendra Kumar},
  title = {Understanding the Involvement of microRNAs in Mitochondrial Dysfunction and Their Role as Potential Biomarkers and Therapeutic Targets in Parkinson’s Disease},
  journal = {Journal of Alzheimer’s Disease},
  year = {2023},
  doi = {10.3233/jad-220449}
}
Kostenlos starten →